AI predicts prostate cancer spread from biopsy
Part of Cancer clinical trials.
This study uses an artificial intelligence (AI) system to look at prostate biopsy samples and predict if the cancer has spread to the lymph nodes. It may help doctors decide on the best treatment without needing extra surgery or scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 90 years old.
- You had a prostate biopsy that found cancer because of a high PSA, an abnormal exam, or unusual imaging.
- You had surgery to remove your prostate and some lymph nodes, and the doctors know if the cancer spread to those lymph nodes.
- You had a scan (like PSMA PET/CT, MRI, or bone scan) to check if the cancer spread to other parts of the body.
- You are generally healthy enough for daily activities (ECOG score 0 or 1).
- You have not had any other cancer in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to examine MRI and other health data to better predict if high-risk prostate cancer has spread to nearby lymph nodes. Researchers hope this will help guide treatment decisions.
This trial tests whether an artificial intelligence (AI) program can help doctors decide when a prostate biopsy is needed. It is for men who have had a prostate MRI that shows either a low-risk (PIRADS 1-2) or uncertain (PIRADS 3) spot, along with a higher-than-normal PSA level. You may qualify if you have certain risk factors like a high PSA density, suspicious digital rectal exam, or family history of prostate cancer.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
This trial uses artificial intelligence to better predict and treat prostate cancer. If you have a suspected prostate cancer diagnosis, your information may help improve AI-based care.
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
Hear when a new Prostate Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.